Total Payments
$1,266
2024 Payments
$33.02
Companies
6
Transactions
16
Medicare Patients
1,256
Medicare Billing
$80,926
Payment Breakdown by Category
Food & Beverage$1,266 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,266 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $394.57 | 6 | $0 (2019) |
| Shire North American Group Inc | $393.23 | 5 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $194.38 | 2 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $125.53 | 1 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $124.99 | 1 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $33.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.02 | 1 | Tarsus Pharmaceuticals, Inc. ($33.02) |
| 2023 | $124.99 | 1 | Apellis Pharmaceuticals, Inc. ($124.99) |
| 2019 | $221.72 | 4 | Allergan Inc. ($119.54) |
| 2018 | $636.67 | 7 | Shire North American Group Inc ($239.83) |
| 2017 | $249.32 | 3 | Shire North American Group Inc ($132.30) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/14/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Ophthalmology | ||||||
| 12/12/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $81.08 | General |
| Category: Glaucoma | ||||||
| 07/24/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/21/2019 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $105.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/20/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: OPTHALMICS | ||||||
| 12/11/2018 | Allergan Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $143.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/28/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/26/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: OPTHALMICS | ||||||
| 10/18/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $120.32 | General |
| Category: OPTHALMICS | ||||||
| 07/12/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $113.30 | General |
| Category: Ophthalmology | ||||||
| 12/05/2017 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $117.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/10/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: OPTHALMICS | ||||||
| 09/26/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 334 | 373 | $56,760 | $23,603 |
| 2022 | 7 | 255 | 270 | $36,088 | $12,017 |
| 2021 | 9 | 394 | 447 | $63,277 | $26,976 |
| 2020 | 6 | 273 | 339 | $49,185 | $18,330 |
Total Patients
1,256
Total Services
1,429
Medicare Billing
$80,926
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 86 | 92 | $17,020 | $7,941 | 46.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 59 | 59 | $13,275 | $6,271 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 85 | $10,625 | $3,894 | 36.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 33 | 34 | $4,420 | $2,180 | 49.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 38 | 43 | $6,020 | $1,789 | 29.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 41 | 45 | $4,050 | $1,101 | 27.2% |
| 92134 | Imaging of retina | Office | 2023 | 15 | 15 | $1,350 | $427.50 | 31.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 69 | 69 | $12,765 | $4,481 | 35.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 25 | 25 | $5,625 | $2,048 | 36.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 54 | 66 | $4,902 | $1,845 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $3,516 | $1,472 | 41.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 37 | 38 | $5,320 | $1,225 | 23.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 32 | 32 | $2,880 | $580.58 | 20.2% |
| 92134 | Imaging of retina | Office | 2022 | 11 | 12 | $1,080 | $365.44 | 33.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 95 | 98 | $18,130 | $7,821 | 43.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 81 | 122 | $15,860 | $7,130 | 45.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 52 | 52 | $11,700 | $5,176 | 44.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 41 | 46 | $3,082 | $2,030 | 65.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 43 | 44 | $6,160 | $1,799 | 29.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $1,590 | $1,083 | 68.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 37 | 39 | $3,510 | $955.18 | 27.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 17 | 18 | $1,620 | $509.88 | 31.5% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 13 | 13 | $1,625 | $470.82 | 29.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 89 | 143 | $18,590 | $7,131 | 38.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 78 | 86 | $15,910 | $7,097 | 44.6% |
About Dr. Ildiko Kondray, MD
Dr. Ildiko Kondray, MD is a Ophthalmology healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275534380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ildiko Kondray, MD has received a total of $1,266 in payments from pharmaceutical and medical device companies, with $33.02 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,266).
As a Medicare-enrolled provider, Kondray has provided services to 1,256 Medicare beneficiaries, totaling 1,429 services with total Medicare billing of $80,926. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Bedford, OH
- Active Since 08/10/2005
- Last Updated 01/14/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275534380
Products in Payments
- XIIDRA (Drug) $393.23
- LUMIGAN (Drug) $393.02
- Rhopressa (Drug) $194.38
- VYZULTA (Drug) $125.53
- Syfovre (Drug) $124.99
- XDEMVY (Drug) $33.02
- COMBIGAN (Drug) $1.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bedford
Dr. Farshid Ighani, Md, MD
Ophthalmology — Payments: $5,510
Ophthalmology $5,510
Drew Davis, M.d, M.D
Ophthalmology — Payments: $4,712
Ophthalmology $4,712
Dr. Brian Anding, M.d, M.D
Ophthalmology — Payments: $1,236
Ophthalmology $1,236
Marc Jones, M.d, M.D
Ophthalmology — Payments: $24.17
Ophthalmology $24.17
Dr. Roland Glassman, Md, MD
Ophthalmology
Ophthalmology
Dr. Carl Marling, Md, MD
Ophthalmology
Ophthalmology